Results 101 to 110 of about 3,667 (197)

Atovaquone-Proguanil (Malarone\u2122) - French

Atovaquone-proguanil is a combination of two drugs, atovaquone and proguanil, in a single tablet.

core  

Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas

Travel Medicine and Infectious Disease
Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas.
Jenny Lea Schnyder, David Cornelis Birkhoff, Myrthe Celine Jarings, Sabine Margot Hermans, Martin Peter Grobusch, Hanna Katrien de Jong   +5 more
doaj   +1 more source

Atovaquone-Proguanil (Malarone\u2122) - Haitian Creole

Atovaquone-proguanil is a combination of two drugs, atovaquone and proguanil, in a single tablet.

core  

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers:a randomised, double-blind study. Malarone International Study Team

, 2000
BACKGROUND: Chloroquine plus proguanil is widely used for malaria chemoprophylaxis despite low effectiveness in areas where multidrug-resistant malaria occurs.

core  

False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report

Reports
Background and Clinical Significance: Fever in the returning traveler is a medical emergency warranting prompt exclusion of potentially life-threatening infections such as malaria.
Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph, Andrea K. Boggild   +3 more
doaj   +1 more source

Pharmacokinetics and dynamics of atovaquone and proguanil (Malarone®)

, 2004
Malarone® is a fixed dose combination of atovaquone and proguanil and is mainly used for prophylaxis against P. falciparum malaria as an alternative to Lariamo® or chloroquine+proguanil.
Mita M Thapar (19491844)
core  

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

Therapeutics and Clinical Risk Management, 2008
V Nicosia1, Giorgio Colombo2, M Consentino1, S Di Matteo2, F Mika1, S De Sanctis1, S Ratti2, Marta Vinci21Saipem Medical Dept. San Donato Milanese, Italy; 2S.A.V.E.
V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al   +5 more
doaj  

Response to Behrens and Edwards: Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence. [PDF]

Travel Med Infect Dis, 2020
Gutman JR, Tan KR.
europepmc   +1 more source

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.

, 2000
Despite its recognized importance, the prevention of patients with malaria from continuing to infect mosquitoes after treatment is not always achieved in practice.
Høgh, B, Sinden, RE, Margos, G, Butcher, G A, Sinden, R E, Enosse, S, Butcher, GA, Mendoza, J, Sinden, Robert   +8 more
core   +1 more source

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: Results of an international, randomized, open-label study

Atovaquone-proguanil has been shown to be effective and well tolerated for malaria prophylaxis in residents of countries of endemicity and in nonimmune adult travelers, but data about traveling children are limited.
Malvy D, Miller GB, Hogh B, Dutoit E, Roskell NS, Djossou F, Brook P, Schilthuis HJ, Hedgley C, De Boever EH, Camus D   +10 more
core